Current gaps in sepsis immunology: new opportunities for translational research

I Rubio, MF Osuchowski, M Shankar-Hari… - The Lancet infectious …, 2019 - thelancet.com
Increasing evidence supports a central role of the immune system in sepsis, but the current
view of how sepsis affects immunity, and vice versa, is still rudimentary. The European …

Advancing precision medicine for acute respiratory distress syndrome

JR Beitler, BT Thompson, RM Baron… - The Lancet …, 2022 - thelancet.com
Acute respiratory distress syndrome (ARDS) is a heterogeneous clinical syndrome.
Understanding of the complex pathways involved in lung injury pathogenesis, resolution …

[HTML][HTML] Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study

FW Hamilton, M Thomas, D Arnold, T Palmer… - PLoS …, 2023 - journals.plos.org
Background Sepsis is characterised by dysregulated, life-threatening immune responses,
which are thought to be driven by cytokines such as interleukin 6 (IL-6). Genetic variants in …

Sepsis: pathophysiology and clinical management

JE Gotts, MA Matthay - Bmj, 2016 - bmj.com
Sepsis, severe sepsis, and septic shock represent increasingly severe systemic
inflammatory responses to infection. Sepsis is common in the aging population, and it …

Community-acquired pneumonia and hospital-acquired pneumonia

CW Lanks, AI Musani, DW Hsia - Medical Clinics, 2019 - medical.theclinics.com
Community-acquired Pneumonia and Hospital-acquired Pneumonia - Medical Clinics Skip to
Main Content Skip to Main Menu Medical Clinics Log in Register Log in Subscribe Claim Main …

[HTML][HTML] Surviving sepsis campaign: research priorities for sepsis and septic shock

CM Coopersmith, D De Backer, CS Deutschman… - Intensive care …, 2018 - Springer
Objective To identify research priorities in the management, epidemiology, outcome and
underlying causes of sepsis and septic shock. Design A consensus committee of 16 …

[HTML][HTML] Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

EE Davenport, KL Burnham… - The Lancet …, 2016 - thelancet.com
Background Effective targeted therapy for sepsis requires an understanding of the
heterogeneity in the individual host response to infection. We investigated this heterogeneity …

Community-acquired pneumonia

E Prina, OT Ranzani, A Torres - The Lancet, 2015 - thelancet.com
Community-acquired pneumonia causes great mortality and morbidity and high costs
worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of …

[HTML][HTML] iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies

VEJM Palasantzas, I Tamargo-Rubio, K Le, J Slager… - Trends in Genetics, 2023 - cell.com
Genome-wide association studies (GWAS) have now correlated hundreds of genetic
variants with complex genetic diseases and drug efficacy. Functional characterization of …

[HTML][HTML] Biomarkers in pneumonia—beyond procalcitonin

M Karakioulaki, D Stolz - International journal of molecular sciences, 2019 - mdpi.com
Pneumonia is the leading infectious cause of mortality worldwide and one of the most
common lower respiratory tract infections that is contributing significantly to the burden of …